Antimicrobial resistant and extended-spectrum ß-lactamase (ESBL) producing Escherichia coli isolated from fecal samples of African dromedary camels

This study was conducted to determine the distribution of antimicrobial resistance among Escherichia coli isolated from feces of healthy dromedary camels in Kenya. A total of 162 fecal samples were cultivated for E. coli. Samples were also subcultivated to detect E. coli with extended-spectrum ß-lac...

Full description

Bibliographic Details
Main Authors: Nüesch-Inderbinen, M., Kindle, P., Baschera, M., Liljander, Anne M., Jores, Joerg, Corman, V.M., Stephan, R.
Format: Journal Article
Language:Inglés
Published: Elsevier 2020
Subjects:
Online Access:https://hdl.handle.net/10568/108128
_version_ 1855529563999698944
author Nüesch-Inderbinen, M.
Kindle, P.
Baschera, M.
Liljander, Anne M.
Jores, Joerg
Corman, V.M.
Stephan, R.
author_browse Baschera, M.
Corman, V.M.
Jores, Joerg
Kindle, P.
Liljander, Anne M.
Nüesch-Inderbinen, M.
Stephan, R.
author_facet Nüesch-Inderbinen, M.
Kindle, P.
Baschera, M.
Liljander, Anne M.
Jores, Joerg
Corman, V.M.
Stephan, R.
author_sort Nüesch-Inderbinen, M.
collection Repository of Agricultural Research Outputs (CGSpace)
description This study was conducted to determine the distribution of antimicrobial resistance among Escherichia coli isolated from feces of healthy dromedary camels in Kenya. A total of 162 fecal samples were cultivated for E. coli. Samples were also subcultivated to detect E. coli with extended-spectrum ß-lactamases (ESBLs). Antimicrobial susceptibility testing (AST) was performed by disk diffusion using a panel of 16 antimicrobials. In addition, isolates were screened for the presence of the plasmid-mediated colistin resistance genes mcr-1 to mcr-5. Samples from 20 (12.4%) of the camels contained antimicrobial resistant (AMR) E. coli, and 85% of the AMR isolates were multidrug resistant (MDR). The highest frequency of resistance was observed to tetracycline (11.7%), followed by ampicillin and streptomycin (both 10.5%), and sulfamethoxazole/trimethoprim (9.9%). Two (1.2%) of the isolates showed intermediate resistance to cefazolin and streptomycin, respectively. All the isolates were susceptible to amoxycillin/clavulanic acid, ciprofloxacin, fosfomycin, aztreonam and kanamycin, and 86.4% of the isolates were susceptible to all 16 antimicrobials used in this study. The prevalence of fecal carriage of ESBL producing E. coli was 0.6%. PCR and amplicon sequencing showed that the ESBL producer belonged to E. coli phylogenetic group A, sequence type (ST) 48, and harbored blaCTX-M-15. None of the isolates contained mcr genes. The results indicate that dromedary camels in Kenya may be reservoirs of AMR E. coli, including ESBL producers, that could potentially be transmitted to humans by direct contact or via the food chain.
format Journal Article
id CGSpace108128
institution CGIAR Consortium
language Inglés
publishDate 2020
publishDateRange 2020
publishDateSort 2020
publisher Elsevier
publisherStr Elsevier
record_format dspace
spelling CGSpace1081282024-05-01T08:18:04Z Antimicrobial resistant and extended-spectrum ß-lactamase (ESBL) producing Escherichia coli isolated from fecal samples of African dromedary camels Nüesch-Inderbinen, M. Kindle, P. Baschera, M. Liljander, Anne M. Jores, Joerg Corman, V.M. Stephan, R. camels antimicrobial resistance animal health This study was conducted to determine the distribution of antimicrobial resistance among Escherichia coli isolated from feces of healthy dromedary camels in Kenya. A total of 162 fecal samples were cultivated for E. coli. Samples were also subcultivated to detect E. coli with extended-spectrum ß-lactamases (ESBLs). Antimicrobial susceptibility testing (AST) was performed by disk diffusion using a panel of 16 antimicrobials. In addition, isolates were screened for the presence of the plasmid-mediated colistin resistance genes mcr-1 to mcr-5. Samples from 20 (12.4%) of the camels contained antimicrobial resistant (AMR) E. coli, and 85% of the AMR isolates were multidrug resistant (MDR). The highest frequency of resistance was observed to tetracycline (11.7%), followed by ampicillin and streptomycin (both 10.5%), and sulfamethoxazole/trimethoprim (9.9%). Two (1.2%) of the isolates showed intermediate resistance to cefazolin and streptomycin, respectively. All the isolates were susceptible to amoxycillin/clavulanic acid, ciprofloxacin, fosfomycin, aztreonam and kanamycin, and 86.4% of the isolates were susceptible to all 16 antimicrobials used in this study. The prevalence of fecal carriage of ESBL producing E. coli was 0.6%. PCR and amplicon sequencing showed that the ESBL producer belonged to E. coli phylogenetic group A, sequence type (ST) 48, and harbored blaCTX-M-15. None of the isolates contained mcr genes. The results indicate that dromedary camels in Kenya may be reservoirs of AMR E. coli, including ESBL producers, that could potentially be transmitted to humans by direct contact or via the food chain. 2020-03 2020-05-01T18:34:25Z 2020-05-01T18:34:25Z Journal Article https://hdl.handle.net/10568/108128 en Open Access Elsevier Nüesch-Inderbinen, M., Kindle, P., Baschera, M., Liljander, A., Jores, J., Corman, V.M. and Stephan, R. 2020. Antimicrobial resistant and extended-spectrum ß-lactamase (ESBL) producing Escherichia coli isolated from fecal samples of African dromedary camels. Scientific African 7: e00274.
spellingShingle camels
antimicrobial resistance
animal health
Nüesch-Inderbinen, M.
Kindle, P.
Baschera, M.
Liljander, Anne M.
Jores, Joerg
Corman, V.M.
Stephan, R.
Antimicrobial resistant and extended-spectrum ß-lactamase (ESBL) producing Escherichia coli isolated from fecal samples of African dromedary camels
title Antimicrobial resistant and extended-spectrum ß-lactamase (ESBL) producing Escherichia coli isolated from fecal samples of African dromedary camels
title_full Antimicrobial resistant and extended-spectrum ß-lactamase (ESBL) producing Escherichia coli isolated from fecal samples of African dromedary camels
title_fullStr Antimicrobial resistant and extended-spectrum ß-lactamase (ESBL) producing Escherichia coli isolated from fecal samples of African dromedary camels
title_full_unstemmed Antimicrobial resistant and extended-spectrum ß-lactamase (ESBL) producing Escherichia coli isolated from fecal samples of African dromedary camels
title_short Antimicrobial resistant and extended-spectrum ß-lactamase (ESBL) producing Escherichia coli isolated from fecal samples of African dromedary camels
title_sort antimicrobial resistant and extended spectrum ss lactamase esbl producing escherichia coli isolated from fecal samples of african dromedary camels
topic camels
antimicrobial resistance
animal health
url https://hdl.handle.net/10568/108128
work_keys_str_mv AT nueschinderbinenm antimicrobialresistantandextendedspectrumßlactamaseesblproducingescherichiacoliisolatedfromfecalsamplesofafricandromedarycamels
AT kindlep antimicrobialresistantandextendedspectrumßlactamaseesblproducingescherichiacoliisolatedfromfecalsamplesofafricandromedarycamels
AT bascheram antimicrobialresistantandextendedspectrumßlactamaseesblproducingescherichiacoliisolatedfromfecalsamplesofafricandromedarycamels
AT liljanderannem antimicrobialresistantandextendedspectrumßlactamaseesblproducingescherichiacoliisolatedfromfecalsamplesofafricandromedarycamels
AT joresjoerg antimicrobialresistantandextendedspectrumßlactamaseesblproducingescherichiacoliisolatedfromfecalsamplesofafricandromedarycamels
AT cormanvm antimicrobialresistantandextendedspectrumßlactamaseesblproducingescherichiacoliisolatedfromfecalsamplesofafricandromedarycamels
AT stephanr antimicrobialresistantandextendedspectrumßlactamaseesblproducingescherichiacoliisolatedfromfecalsamplesofafricandromedarycamels